🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/02/2010 | 35,35 | 35,38 | 34,18 | 35,05 | -1,00% | 3,40% | 24.074.970 |
| 04/02/2010 | 36,63 | 36,75 | 35,13 | 35,40 | -4,18% | 4,40% | 26.547.307 |
| 03/02/2010 | 37,60 | 37,61 | 36,71 | 36,95 | -2,07% | 2,41% | 18.305.311 |
| 02/02/2010 | 36,60 | 37,90 | 36,36 | 37,73 | +3,24% | 4,22% | 15.857.288 |
| 01/02/2010 | 36,79 | 36,86 | 36,33 | 36,55 | +0,31% | 1,45% | 9.666.647 |
| 29/01/2010 | 36,51 | 37,22 | 35,94 | 36,43 | +0,55% | 3,53% | 16.893.655 |
| 28/01/2010 | 36,97 | 37,16 | 36,20 | 36,23 | -1,73% | 2,58% | 14.008.197 |
| 27/01/2010 | 36,73 | 37,00 | 36,22 | 36,87 | +0,16% | 2,13% | 18.322.289 |
| 26/01/2010 | 36,74 | 37,17 | 36,41 | 36,81 | -0,46% | 2,05% | 20.817.158 |
| 25/01/2010 | 37,48 | 37,92 | 36,95 | 36,98 | -0,28% | 2,60% | 16.116.039 |
| 22/01/2010 | 38,07 | 38,44 | 36,99 | 37,09 | -3,02% | 3,81% | 18.301.853 |
| 21/01/2010 | 39,20 | 39,66 | 38,22 | 38,24 | -2,32% | 3,68% | 26.803.019 |
| 20/01/2010 | 38,78 | 39,27 | 38,14 | 39,15 | +1,01% | 2,90% | 21.843.150 |
| 19/01/2010 | 37,74 | 38,97 | 37,63 | 38,76 | +2,91% | 3,54% | 20.908.334 |
| 15/01/2010 | 38,15 | 38,43 | 37,22 | 37,66 | -1,30% | 3,15% | 21.854.258 |
| 14/01/2010 | 37,44 | 38,28 | 37,31 | 38,16 | +2,72% | 2,60% | 23.081.466 |
| 13/01/2010 | 36,56 | 37,57 | 36,36 | 37,15 | +3,67% | 3,31% | 26.593.419 |
| 12/01/2010 | 36,09 | 36,25 | 35,61 | 35,83 | -0,79% | 1,77% | 11.445.942 |
| 11/01/2010 | 36,15 | 36,18 | 35,78 | 36,12 | +0,40% | 1,11% | 10.041.726 |
| 08/01/2010 | 36,14 | 36,15 | 35,72 | 35,97 | -0,05% | 1,21% | 11.283.921 |
| 07/01/2010 | 35,75 | 36,16 | 35,69 | 35,99 | +0,16% | 1,33% | 12.488.597 |
| 06/01/2010 | 35,51 | 36,00 | 35,21 | 35,94 | +1,35% | 2,23% | 15.971.415 |
| 05/01/2010 | 35,59 | 35,73 | 35,24 | 35,46 | +0,41% | 1,39% | 15.452.550 |
| 04/01/2010 | 35,13 | 35,54 | 34,88 | 35,31 | +1,29% | 1,90% | 14.563.532 |
| 31/12/2009 | 35,11 | 35,37 | 34,83 | 34,87 | -1,40% | 1,55% | 7.403.072 |
| 30/12/2009 | 35,19 | 35,49 | 35,12 | 35,36 | -0,11% | 1,03% | 9.838.205 |
| 29/12/2009 | 35,43 | 35,78 | 35,37 | 35,40 | -0,51% | 1,16% | 7.869.013 |
| 28/12/2009 | 35,30 | 35,67 | 35,11 | 35,58 | +0,81% | 1,59% | 10.443.634 |
| 24/12/2009 | 35,44 | 35,44 | 35,08 | 35,30 | -0,70% | 1,02% | 6.586.890 |
| 23/12/2009 | 36,13 | 36,13 | 35,44 | 35,54 | -1,32% | 1,90% | 13.358.542 |